CN101570758A - Method for marking bifluorescence protein molecule cell - Google Patents

Method for marking bifluorescence protein molecule cell Download PDF

Info

Publication number
CN101570758A
CN101570758A CNA2008100368376A CN200810036837A CN101570758A CN 101570758 A CN101570758 A CN 101570758A CN A2008100368376 A CNA2008100368376 A CN A2008100368376A CN 200810036837 A CN200810036837 A CN 200810036837A CN 101570758 A CN101570758 A CN 101570758A
Authority
CN
China
Prior art keywords
recombinant plasmid
lef1
halo
snap
ires
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100368376A
Other languages
Chinese (zh)
Inventor
杨淑伟
黄文韬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institutes for Biological Sciences SIBS of CAS
Original Assignee
Shanghai Institutes for Biological Sciences SIBS of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institutes for Biological Sciences SIBS of CAS filed Critical Shanghai Institutes for Biological Sciences SIBS of CAS
Priority to CNA2008100368376A priority Critical patent/CN101570758A/en
Publication of CN101570758A publication Critical patent/CN101570758A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention provides a recombinant plasmid for a method for marking a bifluorescence protein molecule and a method for marking a bifluorescence protein molecule cell. The recombinant plasmid comprises a segment A coding tag protein A, a segment B coding tag protein B and a promoter at the upper stream of a segment AC, wherein the 5' end or the 3' end of the segment A merges a sequence C coding protein C to be detected; the 5' end or the 3' end of the segment B merges a sequence D coding protein D to be detected; and segments A-C and B-D are connected by an IRES sequence E. The marking method comprises the steps of constructing the recombinant plasmid for the method for marking the bifluorescence protein molecule, cell transfection and fluorescence marking. The recombinant plasmid and the marking method can express two target genes in all in the same carrier, marks two kinds of different proteins in the same cell, has simple and rapid marking process and greatly saves the marking time than that of a traditional antibody fluorescence marking method.

Description

The method of a kind of pair of fluorescin molecular cell mark
Technical field
The invention belongs to biological technical field, specifically, relate to the method for a kind of pair of fluorescin molecular cell mark.
Background technology
Fluorescence microscopy provides an extremely useful instrument for the research of cytobiology, and by intuitive image, the research protein molecular is in intracellular dynamic behaviour.As the secretion of protein molecular, endocytosis, transportation, the location proteinicly goes out nuclear and goes into nuclear, the interaction of intracellular protein molecule etc.Traditional method is (as GFP by protein molecular and label protein, YFP, Flag, the be stimulated fluorescence of the various different wave lengths that the back sent of amalgamation and expression such as HA.....), the autofluorescence by GFP in cell or the corresponding antibodies link coupled fluorescence molecule of various label proteins reaches the purpose of observation.
But because the method antibody of antibody can not freely enter or cell so be not suitable for doing the mark of viable cell, though and the method for GFP can be used for the mark of viable cell, but since the albumen that GFP merges can be on emission wavelength continuous emitting fluorescence, this is influence to some extent concerning the research of some dynamicss, therefore, necessaryly provide a kind of new marking method, to overcome the defective that exists in the above-mentioned traditional method.
Summary of the invention
The objective of the invention is to, a kind of pair of fluorescin molecular recombination plasmid is provided, to carry out two fluorescin molecular cell marks.
A further object of the invention is, the method for a kind of pair of fluorescin molecular cell mark is provided.
The recombinant plasmid that is used for two fluorescin molecular labeling method methods provided by the invention, comprise: 1) the dna fragmentation A of coded polypeptide A (being label protein A), this label protein can be specifically and the combining of its fluorogenic substrate covalency, and its 5 ' end or 3 ' end can merge the dna sequence dna C of one section coding PROTEIN C to be detected; 2) the dna fragmentation B of coded polypeptide B (being label protein B), this label protein can be specifically and the combining of its fluorogenic substrate covalency, and its 5 ' end or 3 ' end can merge the dna sequence dna D of one section coding protein D to be detected; 3) be to link together between Segment A-C and the B-D by bicistronic mRNA ORF expression system sequence (IRES) the dna sequence dna E that an intersegmental part rrna inserts the site element; 4) at a section responsible dna fragmentation AC, E of the correct position of the upstream of Segment A C and the DNA element of transcribing control (being promotor) of BD.
According to a preferred embodiment of the present invention, described label protein comprises SNAP, Halo.
The method of provided by the invention pair of fluorescin molecular cell mark may further comprise the steps: make up the recombinant plasmid, cell transfecting and the fluorescent mark that are used for two fluorescin molecular labeling method methods.
According to a preferred embodiment of the present invention, use the marking method provided by the invention can be at arbitrary time image of cell, for example m period carries out mark.
Use recombinant plasmid provided by the invention, can in same carrier, work in coordination with two goal gene of coexpression, need not to worry issuable problem in the efficient of cotransfection and other cotransfection process, can be well with two different albumen in the same cell of tense marker, utilize different fluorescence on the substrate band separately, under the same visual field, can observe two kinds of protein molecular location in cell simultaneously, two kinds of marking methods can not disturbed each other to some extent, can carry out mark simultaneously, can not influence the specificity of mark, can not influence the correct location of protein molecular; And labeling process is simple, fast, can in 15-30 minute, finish mark, save time of mark greatly than traditional antibody fluorescence labeling method, simultaneously, its marking method can be carried out mark at arbitrary time image of cell, therefore can observe the situation of cell at the target protein of different time images.
Description of drawings
Figure 1A is the recombinant plasmid synoptic diagram that is used for two fluorescin molecule marking methods.
Figure 1B is an example pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid synoptic diagram.
Fig. 2 is that internal ribosome inserts site (IRES) bicistronic mRNA ORF expression system synoptic diagram.
Fig. 3 is electrophoresis detection figure as a result, and wherein Fig. 3 A is the segmental PCR product of amplification LEF1 electrophoresis result, and Fig. 3 B is the segmental PCR product of amplification SNAP Tag electrophoresis result, and Fig. 3 C is the segmental PCR product of amplification TOM20 electrophoresis result.
Fig. 4 is the common marker detection result of Two Colour Fluorescence, wherein, 4A and 4B be respectively TOM20-SNAP (SNAP-cellTMR-Star) and LEF1-Halo (
Figure A20081003683700051
DiAcFAM Ligand) positioning result, 4C be TOM20-SNAP (SNAP-cell TMR-Star) and LEF1-Halo ( DiAcFAM Ligand) common positioning result.
Fig. 5 is the common marker detection result of Two Colour Fluorescence, wherein, 5A and 5B be respectively TOM20-SNAP0 (SNAP-cellBG505) and LEF1-Halo (
Figure A20081003683700053
TMR Ligand) positioning result, 5C be TOM20-SNAP0 (SNAP-cellBG505) and LEF1-Halo (
Figure A20081003683700054
TMR Ligand) common positioning result.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described.Should be understood that following examples only are used to the present invention is described but not are used to limit scope of the present invention.
The experimental technique of unreceipted actual conditions in the following example, usually according to normal condition, the condition described in " molecular cloning: laboratory manual " (New York:Cold Spring Harbor Laboratory Press, 1989) is carried out.
Embodiment 1, construction of recombinant plasmid
In the present embodiment, the contriver has made up the pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid, in this plasmid, the contriver has cloned into the pTOM20-SNAP-IRES-LEF1-Halo fragment, wherein, albumen LEF1 is the protein molecular in the Wnt signal path, mainly is positioned in the nucleus, albumen TOM20 is the albumen on the mitochondrial outer membrane, and it is positioned on the plastosome; IRES is the bicistronic mRNA ORF expression system that internal ribosome inserts the site element, make to work in coordination with under the same promotor of two genes in a carrier and express two ORF efficiently, first cistron expression cassette has merged SNAP at the C end, and second then is amalgamation and expression Halo.
The segmental structure of pTOM20-SNAP-IRES-LEF1-Halo comprises following 4 steps: 1, will be connected to by the LEF1 that PCR obtains in the pFC14A carrier with Halo, and obtain the pFC14A-LEF1 recombinant plasmid; 2, cut by enzyme LEF1-Halo is joined in the pIRES carrier, obtain the IRES-LEF1-Halo recombinant plasmid; 3, will join by the SNAP tag that PCR obtains in the IRES-LEF1-Halo recombinant plasmid, obtain the SNAP-IRES-LEF1-Halo recombinant plasmid; 4, will join by the TOM20 that PCR obtains in the SNAP-IRES-LEF1-Halo recombinant plasmid, and obtain the TOM20-SNAP-IRES-LEF1-Halo recombinant plasmid, concrete steps are as follows:
1.1, design of primers
Designed respectively and be used to make up the segmental PCR primer of pTOM20-SNAP-IRES-LEF1-Halo, be respectively the primer a1 and the a2 that are used for step 1, be used for the primer c1 and the c2 of step 3 and be used for the primer d1 and the d2 of step 4, shown in its sequence is specific as follows:
a1:AATAGGGCTAGCGATCGCCATGCCCCAACTTTCCGGAGG
a2:GAATTCGGTCTCCTCGAGGATGTAGGCAGCTGTCATTC
c1:AATAGGGCTAGCAGAATTCGCGGCCGCATGGACAAAGACTGCGAAAT
c2:TTCGACGCGTCTTAAACTTGACCCAGCCCAGGC
d1:AATAGGGCTAGCGATCGCCATGGTGGGTCGGAACAGCGC
d2:GAATTCACTCGAGCTTGTCGTCATCGTCTTTGTAGTCTTCCACATCATCTTCAGCCA
1.2, preparation pFC14A-LEF1 recombinant plasmid
1.2.1, amplification LEF1 fragment
The reference product service manual uses SuperScript TMIII test kit (available from Invitrogen), the construction cDNA library.
With the cDNA library that builds is template, is that primer is right with primer a1 and a2, carries out pcr amplification, obtains the LEF1 fragment, and concrete steps are as follows:
Reaction system (50ul): cNDA 2ul; Each 1ul of primer a1 and a2; Pfu enzyme 1ul; 10 * Pfu buffer 5ul; DNTP 1ul; H 2O 39ul.
Response procedures: 94 ℃ of 2min; 94 ℃ of 30sec, 58 ℃ of 30sec, 72 ℃ of 2min; 30 circulations, 72 ℃ of 10min.
The Agrose glue of PCR product race 0.8% is detected, and the result has band at the 1.2kb place as shown in Figure 3A.
Then, the reference product service manual uses QIAEX II Gel Extraction Kit 150 test kits (available from Qiagen) to carry out glue and reclaims, and will reclaim product and check order, and sequencing result shows that reclaiming product is the LEF1 fragment.
1.2.2, the pFC14A-LEF1 construction of recombinant plasmid
Use NheI and XhoI enzyme to cut the LEF1 fragment, enzyme is cut the product gel electrophoresis detection, and carries out glue with QIAEX II GelExtraction Kit 150 test kits and reclaim, and obtains the endonuclease bamhi of LEF1; Then with the endonuclease bamhi that obtains be connected the acquisition recombinant plasmid equally with the pFC14A carrier (available from Promega) that the XhoI enzyme is cut through NheI.
With this recombinant plasmid transformed escherichia coli DH5a, incubated overnight, little sampling observation is tested, and the plasmid that will take out acquisition for a short time checks order, and the result shows and comprises required purpose fragment in this recombinant plasmid, called after pFC14A-LEF1 recombinant plasmid.
1.3, the pIRES-LEF1-Halo construction of recombinant plasmid
The reference product service manual, reclaim the pFC14A-LEF1 recombinant plasmid with QIAprep Spin Miniprep Kit 250 test kits (available from Qiagen), use the NheI/XbaI enzyme to cut the pFC14A-LEF1 recombinant plasmid then, obtain the LEF1-Halo fragment after enzyme is cut, itself and the pIRES carrier of cutting through the XbaI/SalI enzyme were carried out for one sticking one flat flat connection of benefit, obtain recombinant plasmid.
With this recombinant plasmid transformed escherichia coli DH5a, incubated overnight, little sampling observation is tested, and the plasmid that will take out acquisition for a short time checks order, and the result shows in the plasmid of acquisition and comprises required purpose fragment, called after pIRES-LEF1-Halo recombinant plasmid.
1.4, the SNAP-IRES-LEF1-Halo construction of recombinant plasmid
With pSEMS1-26m-NLS (available from Covalys) is template, is that primer is right with primer c1 and c2, presses the condition of embodiment 1.2.1, carries out pcr amplification, then the PCR product is carried out detected through gel electrophoresis, and the result has located band about 500bp shown in Fig. 3 B.And the reference product handbook, use QIAEX II Gel Extraction Kit 150 test kit glue to reclaim SNAP Tag fragment.
Use NheI and XhoI enzyme to cut SNAP Tag fragment, then with the endonuclease bamhi that obtains be connected the acquisition recombinant plasmid equally with the pIRES-LEF1-Halo recombinant plasmid that the XhoI enzyme is cut through NheI.
With this recombinant plasmid transformed escherichia coli DH5a, incubated overnight, little sampling observation is tested, and the plasmid that will take out acquisition for a short time checks order, and the result shows in the plasmid of acquisition and comprises required purpose fragment, called after SNAP-IRES-LEF1-Halo recombinant plasmid.
1.5, the pTOM20-SNAP-IRES-LEF1-Halo construction of recombinant plasmid
With human cDNA library is template, is that primer is right with primer d1 and d2, presses the condition of embodiment 1.2.1, carries out pcr amplification, then the PCR product is carried out detected through gel electrophoresis, and the result has located band about 500bp shown in Fig. 3 C.And the reference product handbook, use QIAEX II Gel Extraction Kit 150 test kit glue to reclaim the TOM20 fragment.
Use NheI and XhoI enzyme to cut the TOM20 fragment, then with the endonuclease bamhi that obtains be connected the acquisition recombinant plasmid equally with the SNAP-IRES-LEF1-Halo recombinant plasmid that the XhoI enzyme is cut through NheI.
With these recombinant plasmid transformed intestinal bacteria, after the incubated overnight, little sampling observation is tested, and the plasmid that will take out acquisition for a short time checks order, sequencing result is shown in SEQ ID NO:1, according to sequencing result, comprise required pTOM20-SNAP-IRES-LEF1-Halo fragment in the recombinant plasmid of acquisition, called after pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid.
Embodiment 2, transfectional cell and fluorescent mark
2.1, cell transfecting
Use the Lipo-plus method, transfection Hela cell, concrete steps are as follows:
(1) the medical alcohol washing and sterilizing is good slide is put into 24 orifice plates, and by behind the 30min, with sterilization washing 3-5 time, flush away does not wrap the PLL of quilt, dries on super clean bench with poly-lysine PLL (Poly-L-Lysine) bag;
(2) the Hela cell in wrapping by 24 orifice plates of good slide, was cultivated 24 hours PLL;
(3) get 250ng pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid and join in the EP pipe that contains 25ul serum-free DMEM nutrient solution, and mixing;
(4) get transfection reagent plus, be diluted in the DMEM nutrient solution with 1: 20, mixing adds in the EP pipe of going up the step with the amount of 21ul/ pipe, and mixing left standstill 15 minutes;
(5) get transfection reagent lipo, be diluted in the DMEM nutrient solution with 1: 20, mixing adds in the EP pipe of going up the step with the amount of 21ul/ pipe, and mixing left standstill 15 minutes;
Repeating step (3)-(5), the nutrient solution that contains plasmid and transfection reagent of configuration capacity;
(6) absorb original fluid, and add 200ul DMEM nutrient solution to each hole;
After (7) one hours, drip the nutrient solution that contains plasmid that 67ul obtains respectively in step 6 to every hole;
After (8) 3 hours, absorb original nutrient solution, add the nutrient solution that 500ul contains 10% foetal calf serum; Cultivate and be used for following fluorescent mark after 24 hours.
2.2, fluorescent mark
Divide two groups during the culturing cell that obtains in embodiment 2.1 is cultivated, one group of cell adds
Figure A20081003683700091
DiAcFAMLigand (available from Promega) and SNAP-cell TMR-Star (available from Covalys), another group cell adds TMR Ligand (available from Promega) and SNAP-cell BG505 (available from Covalys) carry out fluorescent mark and detect, wherein,
Figure A20081003683700093
To be diluted to jointly in 1: 500 and 1: 100 in 37 ℃ the DMEM substratum that contains 10%FBS, concrete steps are as follows respectively for Ligand and SNAP-cell ligand:
(1) the former substratum in each hole among the embodiment 2.1 is siphoned away to the remaining 100ul of I, drip in each hole then that 100ul is above-mentioned to be contained
Figure A20081003683700094
The DMEM substratum of Ligand and SNAP-cell ligand;
(2) place 37 ℃, 5%CO 2In the incubator, lucifuge was cultivated 15-30 minute.
(3) after above-mentioned DMEM substratum is removed in suction,, in each hole, add 400ul PBS and wash in 37 ℃;
(4) after PBS is removed in suction, fix 10 minutes with the formaldehyde lucifuge of freshly prepared 400ul 4%;
(5) after stationary liquid is removed in suction, with the PBS that contains 400ul 0.1%TritonX-100, penetrating 30 minutes;
(6) drop of resin that mounting is used is on slide glass, and the cover glass that mark is good on 24 orifice plates is placed resin on the slide glass, carries out the observation of Confocal fluorescent microscope after drying.
Observed result such as Fig. 4, shown in Figure 5, plastosome among Fig. 4 A and Fig. 5 A respectively on the mark red and green fluorescence, on the nucleus among Fig. 4 B and Fig. 5 B on the mark green and red fluorescence, two kinds of fluorescence of Fig. 4 C and Fig. 5 C are localized result altogether.According to Fig. 4, the result of Fig. 5, LEF1-Halo accurately navigates on the nucleus; TOM20-SNAP also accurately is positioned on the plastosome, and LEF1-Halo and TOM20-SNAP also are positioned in the cell well altogether.
According to The above results, use the pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid, carry out cell transfecting and fluorescent mark and detect, the result of acquisition can not disturb each other to some extent.
Though; in pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid of the present invention; what use is that IRES expresses pTOM20-SNAP to reach on same carrier; two proteic purposes of LEF1-Halo; but for a person skilled in the art; the method and the spirit that disclose according to the present invention; utilization two promotors on same carrier are expressed pTOM20-SNAP respectively; two albumen of LEF1-Halo reach identical effect; this is conspicuous; therefore, also be the content that the present invention needs protection.
Though; in pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid of the present invention; SNAP and Halo all place separately after the albumen; but place proteic separately front and back to its active nothing influence SNAP and Halo; selected according to proteic characteristic separately; therefore, also be the content that the present invention needs protection.
Though; in pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid of the present invention; the detected albumen that uses is respectively pTOM20 and LEF1; but the method and the spirit that disclose according to the present invention; use other detected albumen, the detected proteic recombinant plasmid that structure can be expressed simultaneously, this is conspicuous for a person skilled in the art; therefore, also be the content that the present invention needs protection.
Though; in an embodiment of the present invention; the small molecules substrate adds; but two kinds of markers are that the order that can add simultaneously or add respectively and add can not distinguished to some extent; can be selected easily by experimental needs on the contrary; this is conspicuous for a person skilled in the art, therefore, also is the content that the present invention needs protection.
In sum, use method provided by the invention, can in same carrier, work in coordination with two goal gene of coexpression, need not to worry issuable problem in the efficient of cotransfection and other cotransfection processes, can be well with two different albumen in the same cell of tense marker, utilize different fluorescence on the substrate band separately, under the same visual field, can observe two kinds of protein molecular location in cell simultaneously, two kinds of marking methods can not disturbed each other to some extent, can carry out mark simultaneously, can not influence the specificity of mark, can not influence the correct location of protein molecular; And labeling process is simple, fast, can in 15-30 minute, finish mark, save time of mark greatly than traditional antibody fluorescence labeling method, simultaneously, its marking method can be carried out mark at arbitrary time image of cell, therefore can observe the situation of cell at the target protein of different time images.
Sequence table
<110〉Shanghai Inst. of Life Science, CAS
<120〉method of a kind of pair of fluorescin molecular cell mark
<130>P5081018
<160>1
<170>PatentIn?version?3.1
<210>1
<211>9233
<212>DNA
<213〉intestinal bacteria
<400>1
tcaatattgg?ccattagcca?tattattcat?tggttatata?gcataaatca?atattggcta 60
ttggccattg?catacgttgt?atctatatca?taatatgtac?atttatattg?gctcatgtcc 120
aatatgaccg?ccatgttggc?attgattatt?gactagttat?taatagtaat?caattacggg 180
gtcattagtt?catagcccat?atatggagtt?ccgcgttaca?taacttacgg?taaatggccc 240
gcctggctga?ccgcccaacg?acccccgccc?attgacgtca?ataatgacgt?atgttcccat 300
agtaacgcca?atagggactt?tccattgacg?tcaatgggtg?gagtatttac?ggtaaactgc 360
ccacttggca?gtacatcaag?tgtatcatat?gccaagtccg?ccccctattg?acgtcaatga 420
cggtaaatgg?cccgcctggc?attatgccca?gtacatgacc?ttacgggact?ttcctacttg 480
gcagtacatc?tacgtattag?tcatcgctat?taccatggtg?atgcggtttt?ggcagtacac 540
caatgggcgt?ggatagcggt?ttgactcacg?gggatttcca?agtctccacc?ccattgacgt 600
caatgggagt?ttgttttggc?accaaaatca?acgggacttt?ccaaaatgtc?gtaacaactg 660
cgatcgcccg?ccccgttgac?gcaaatgggc?ggtaggcgtg?tacggtggga?ggtctatata 720
agcagagctc?gtttagtgaa?ccgtcagatc?actagaagct?ttattgcggt?agtttatcac 780
agttaaattg?ctaacgcagt?cagtgcttct?gacacaacag?tctcgaactt?aagctgcagt 840
gactctctta?aggtagcctt?gcagaagttg?gtcgtgaggc?actgggcagg?taagtatcaa 900
ggttacaaga?caggtttaag?gagaccaata?gaaactgggc?ttgtcgagac?agagaagact 960
cttgcgtttc?tgataggcac?ctattggtct?tactgacatc?cactttgcct?ttctctccac 1020
aggtgtccac?tcccagttca?attacagctc?ttaaggctag?agtacttaat?acgactcact 1080
ataggctagc?gatcgccatg?gtgggtcgga?acagcgccat?cgccgccggt?gtatgcgggg 1140
cccttttcat?tgggtactgc?atctacttcg?accgcaaaag?acgaagtgac?cccaacttca 1200
agaacaggct?tcgagaacga?agaaagaaac?agaagcttgc?caaggagaga?gctgggcttt 1260
ccaagttacc?tgaccttaaa?gatgctgaag?ctgttcagaa?gttcttcctt?gaagaaatac 1320
agcttggtga?agagttacta?gctcaaggtg?aatatgagaa?gggcgtagac?catctgacaa 1380
atgctattgc?tgtgtgtgga?cagccacagc?agttactgca?ggtcttacag?caaactcttc 1440
caccaccagt?gttccagatg?cttctgacta?agctcccaac?aattagtcag?agaattgtaa 1500
gtgctcagag?cttggctgaa?gatgatgtgg?aatgcggccg?catggacaaa?gactgcgaaa 1560
tgaagcgcac?caccctggat?agccctctgg?gcaagctgga?actgtctggg?tgcgaacagg 1620
gcctgcacga?gatcaagctg?ctgggcaaag?gaacatctgc?cgccgacgcc?gtggaagtgc 1680
ctgccccagc?cgccgtgctg?ggcggaccag?agccactgat?gcaggccacc?gcctggctca 1740
acgcctactt?tcaccagcct?gaggccatcg?aggagttccc?tgtgccagcc?ctgcaccacc 1800
cagtgttcca?gcaggagagc?tttacccgcc?aggtgctgtg?gaaactgctg?aaagtggtga 1860
agttcggaga?ggtcatcagc?taccagcagc?tggccgccct?ggccggcaat?cccgccgcca 1920
ccgccgccgt?gaaaaccgcc?ctgagcggaa?atcccgtgcc?cattctgatc?ccctgccacc 1980
gggtggtgtc?tagctctggc?gccgtggggg?gctacgaggg?cgggctcgcc?gtgaaagagt 2040
ggctgctggc?ccacgagggc?cacagactgg?gcaagcctgg?gctgggtcaa?gtttaagacg 2100
cgtcgagcat?gcatctaggg?cggccaattc?cgcccctctc?cctccccccc?ccctaacgtt 2160
actggccgaa?gccgcttgga?ataaggccgg?tgtgcgtttg?tctatatgtg?attttccacc 2220
atattgccgt?cttttggcaa?tgtgagggcc?cggaaacctg?gccctgtctt?cttgacgagc 2280
attcctaggg?gtctttcccc?tctcgccaaa?ggaatgcaag?gtctgttgaa?tgtcgtgaag 2340
gaagcagttc?ctctggaagc?ttcttgaaga?caaacaacgt?ctgtagcgac?cctttgcagg 2400
cagcggaacc?ccccacctgg?cgacaggtgc?ctctgcggcc?aaaagccacg?tgtataagat 2460
acacctgcaa?aggcggcaca?accccagtgc?cacgttgtga?gttggatagt?tgtggaaaga 2520
gtcaaatggc?tctcctcaag?cgtattcaac?aaggggctga?aggatgccca?gaaggtaccc 2580
cattgtatgg?gatctgatct?ggggcctcgg?tgcacatgct?ttacatgtgt?ttagtcgagg 2640
ttaaaaaaac?gtctaggccc?cccgaaccac?ggggacgtgg?ttttcctttg?aaaaacacga 2700
tgataagctt?gccacaaccc?gggatcctct?agcgatcgcc?atgccccaac?tttccggagg 2760
aggcggcggg?ggggacccgg?aactctgcgc?caccgatgag?atgatcccct?tcaaggacga 2820
aggcgatccc?cagaaggaga?agatcttcgc?cgagatcagt?catcccgaag?aggagggcga 2880
cttagccgac?atcaagtcat?ctttggttaa?cgagtccgaa?atcatcccag?ccagcaacgg 2940
gcatgaggtg?gtcagacaag?ccccgtcctc?tcaggagccc?taccacgaca?aggccagaga 3000
acaccctgat?gaaggaaagc?atccagacgg?aggcctgtac?aacaagggac?cctcctactc 3060
cagttactct?ggctacataa?tgatgcccaa?tatgaacagc?gacccgtaca?tgtcaaatgg 3120
gtccctttct?ccacccatcc?cgaggacatc?aaataaagtg?cccgtggtgc?agccctctca 3180
cgcggtccac?ccgctcaccc?ccctcatcac?ctacagcgac?gagcactttt?ctccgggatc 3240
ccacccgtca?cacatcccgt?cagatgtcaa?ctccaagcaa?ggcatgtcca?gacaccctcc 3300
agctcctgaa?atccccacct?tctaccccct?gtctccgggc?ggcgttggac?agatcacccc 3360
acccattggc?tggcaaggtc?agcctgttta?tcccatcacg?ggtggattca?ggcaacccta 3420
cccatcctca?ctgtcaggcg?acacttccat?gtccaggttt?tcccatcata?tgattcctgg 3480
tccccctggc?ccccacacaa?ctggcatccc?tcatccagct?attgtaacac?ctcaggtcaa 3540
acaggagcac?ccccacacgg?acagtgacct?aatgcacgtg?aagcctcaac?acgaacagag 3600
aaaggagcag?gagcccaaaa?gacctcatat?taagaagcct?ctgaatgctt?tcatgttata 3660
tatgaaagaa?atgagagcga?atgtcgtagc?tgagtgcacg?ctaaaggaga?gtgcagctat 3720
caaccagatc?ctgggcagaa?gatggcacgc?cctctcccgg?gaagagcagg?ccaaatacta 3780
tgaactagca?cggaaagaga?gacagctaca?catgcagctt?tatccaggct?ggtcagcgcg 3840
agacaattat?ggcaagaaga?agaagaggaa?gagagagaag?ctacaggagt?cgacttcagg 3900
tacaggtccc?agaatgacag?ctgcctacat?cctcgagcca?accactgagg?atctgtactt 3960
tcagagcgat?aacgatggat?ccgaaatcgg?tactggcttt?ccattcgacc?cccattatgt 4020
ggaagtcctg?ggcgagcgca?tgcactacgt?cgatgttggt?ccgcgcgatg?gcacccctgt 4080
gctgttcctg?cacggtaacc?cgacctcctc?ctacgtgtgg?cgcaacatca?tcccgcatgt 4140
tgcaccgacc?catcgctgca?ttgctccaga?cctgatcggt?atgggcaaat?ccgacaaacc 4200
agacctgggt?tatttcttcg?acgaccacgt?ccgcttcatg?gatgccttca?tcgaagccct 4260
gggtctggaa?gaggtcgtcc?tggtcattca?cgactggggc?tccgctctgg?gtttccactg 4320
ggccaagcgc?aatccagagc?gcgtcaaagg?tattgcattt?atggagttca?tccgccctat 4380
cccgacctgg?gacgaatggc?cagaatttgc?ccgcgagacc?ttccaggcct?tccgcaccac 4440
cgacgtcggc?cgcaagctga?tcatcgatca?gaacgttttt?atcgagggta?cgctgccgat 4500
gggtgtcgtc?cgcccgctga?ctgaagtcga?gatggaccat?taccgcgagc?cgttcctgaa 4560
tcctgttgac?cgcgagccac?tgtggcgctt?cccaaacgag?ctgccaatcg?ccggtgagcc 4620
agcgaacatc?gtcgcgctgg?tcgaagaata?catggactgg?ctgcaccagt?cccctgtccc 4680
gaagctgctg?ttctggggca?ccccaggcgt?tctgatccca?ccggccgaag?ccgctcgcct 4740
ggccaaaagc?ctgcctaact?gcaaggctgt?ggacatcggc?ccgggtctga?atctgctgca 4800
agaagacaac?ccggacctga?tcggcagcga?gatcgcgcgc?tggctgtcta?ctctggagat 4860
ttccggttaa?tagaattcta?gcccccggga?ggccgcttcc?ctttagtgag?ggttaatgct 4920
tcgagcagac?atgataagat?acattgatga?gtttggacaa?accacaacta?gaatgcagtg 4980
aaaaaaatgc?tttatttgtg?aaatttgtga?tgctattgct?ttatttgtaa?ccattataag 5040
ctgcaataaa?caagttaaca?acaacaattg?cattcatttt?atgtttcagg?ttcaggggga 5100
gatgtgggag?gttttttaaa?gcaagtaaaa?cctctacaaa?tgtggtaaaa?tccgataagg 5160
atcgatccgg?gctggcgtaa?tagcgaagag?gcccgcaccg?atcgcccttc?ccaacagttg 5220
cgcagcctga?atggcgaatg?gacgcgccct?gtagcggcgc?attaagcgcg?gcgggtgtgg 5280
tggttacgcg?cagcgtgacc?gctacacttg?ccagcgccct?agcgcccgct?cctttcgctt 5340
tcttcccttc?ctttctcgcc?acgttcgccg?gctttccccg?tcaagctcta?aatcgggggc 5400
tccctttagg?gttccgattt?agagctttac?ggcacctcga?ccgcaaaaaa?cttgatttgg 5460
gtgatggttc?acgtagtggg?ccatcgccct?gatagacggt?ttttcgccct?ttgacgttgg 5520
agtccacgtt?ctttaatagt?ggactcttgt?tccaaactgg?aacaacactc?aaccctatct 5580
cggtctattc?ttttgattta?taagggattt?tgccgatttc?ggcctattgg?ttaaaaaatg 5640
agctgattta?acaaatattt?aacgcgaatt?ttaacaaaat?attaacgttt?acaatttcgc 5700
ctgatgcggt?attttctcct?tacgcatctg?tgcggtattt?cacaccgcat?acgcggatct 5760
gcgcagcacc?atggcctgaa?ataacctctg?aaagaggaac?ttggttaggt?accttctgag 5820
gcggaaagaa?ccagctgtgg?aatgtgtgtc?agttagggtg?tggaaagtcc?ccaggctccc 5880
cagcaggcag?aagtatgcaa?agcatgcatc?tcaattagtc?agcaaccagg?tgtggaaagt 5940
ccccaggctc?cccagcaggc?agaagtatgc?aaagcatgca?tctcaattag?tcagcaacca 6000
tagtcccgcc?cctaactccg?cccatcccgc?ccctaactcc?gcccagttcc?gcccattctc 6060
cgccccatgg?ctgactaatt?ttttttattt?atgcagaggc?cgaggccgcc?tcggcctctg 6120
agctattcca?gaagtagtga?ggaggctttt?ttggaggcct?aggcttttgc?aaaaagcttg 6180
attcttctga?cacaacagtc?tcgaacttaa?ggctagagcc?accatgattg?aacaagatgg 6240
attgcacgca?ggttctccgg?ccgcttgggt?ggagaggcta?ttcggctatg?actgggcaca 6300
acagacaatc?ggctgctctg?atgccgccgt?gttccggctg?tcagcgcagg?ggcgcccggt 6360
tctttttgtc?aagaccgacc?tgtccggtgc?cctgaatgaa?ctgcaggacg?aggcagcgcg 6420
gctatcgtgg?ctggccacga?cgggcgttcc?ttgcgcagct?gtgctcgacg?ttgtcactga 6480
agcgggaagg?gactggctgc?tattgggcga?agtgccgggg?caggatctcc?tgtcatctca 6540
ccttgctcct?gccgagaaag?tatccatcat?ggctgatgca?atgcggcggc?tgcatacgct 6600
tgatccggct?acctgcccat?tcgaccacca?agcgaaacat?cgcatcgagc?gagcacgtac 6660
tcggatggaa?gccggtcttg?tcgatcagga?tgatctggac?gaagagcatc?aggggctcgc 6720
gccagccgaa?ctgttcgcca?ggctcaaggc?gcgcatgccc?gacggcgagg?atctcgtcgt 6780
gacccatggc?gatgcctgct?tgccgaatat?catggtggaa?aatggccgct?tttctggatt 6840
catcgactgt?ggccggctgg?gtgtggcgga?ccgctatcag?gacatagcgt?tggctacccg 6900
tgatattgct?gaagagcttg?gcggcgaatg?ggctgaccgc?ttcctcgtgc?tttacggtat 6960
cgccgctccc?gattcgcagc?gcatcgcctt?ctatcgcctt?cttgacgagt?tcttctgagc 7020
gggactctgg?ggttcgaaat?gaccgaccaa?gcgacgccca?acctgccatc?acgatggccg 7080
caataaaata?tctttatttt?cattacatct?gtgtgttggt?tttttgtgtg?aatcgatagc 7140
gataaggatc?cgcgtatggt?gcactctcag?tacaatctgc?tctgatgccg?catagttaag 7200
ccagccccga?cacccgccaa?cacccgctga?cgcgccctga?cgggcttgtc?tgctcccggc 7260
atccgcttac?agacaagctg?tgaccgtctc?cgggagctgc?atgtgtcaga?ggttttcacc 7320
gtcatcaccg?aaacgcgcga?gacgaaaggg?cctcgtgata?cgcctatttt?tataggttaa 7380
tgtcatgata?ataatggttt?cttagacgtc?aggtggcact?tttcggggaa?atgtgcgcgg 7440
aacccctatt?tgtttatttt?tctaaataca?ttcaaatatg?tatccgctca?tgagacaata 7500
accctgataa?atgcttcaat?aatattgaaa?aaggaagagt?atgagtattc?aacatttccg 7560
tgtcgccctt?attccctttt?ttgcggcatt?ttgccttcct?gtttttgctc?acccagaaac 7620
gctggtgaaa?gtaaaagatg?ctgaagatca?gttgggtgca?cgagtgggtt?acatcgaact 7680
ggatctcaac?agcggtaaga?tccttgagag?ttttcgcccc?gaagaacgtt?ttccaatgat 7740
gagcactttt?aaagttctgc?tatgtggcgc?ggtattatcc?cgtattgacg?ccgggcaaga 7800
gcaactcggt?cgccgcatac?actattctca?gaatgacttg?gttgagtact?caccagtcac 7860
agaaaagcat?cttacggatg?gcatgacagt?aagagaatta?tgcagtgctg?ccataaccat 7920
gagtgataac?actgcggcca?acttacttct?gacaacgatc?ggaggaccga?aggagctaac 7980
cgcttttttg?cacaacatgg?gggatcatgt?aactcgcctt?gatcgttggg?aaccggagct 8040
gaatgaagcc?ataccaaacg?acgagcgtga?caccacgatg?cctgtagcaa?tggcaacaac 8100
gttgcgcaaa?ctattaactg?gcgaactact?tactctagct?tcccggcaac?aattaataga 8160
ctggatggag?gcggataaag?ttgcaggacc?acttctgcgc?tcggcccttc?cggctggctg 8220
gtttattgct?gataaatctg?gagccggtga?gcgtgggtct?cgcggtatca?ttgcagcact 8280
ggggccagat?ggtaagccct?cccgtatcgt?agttatctac?acgacgggga?gtcaggcaac 8340
tatggatgaa?cgaaatagac?agatcgctga?gataggtgcc?tcactgatta?agcattggta 8400
actgtcagac?caagtttact?catatatact?ttagattgat?ttaaaacttc?atttttaatt 8460
taaaaggatc?taggtgaaga?tcctttttga?taatctcatg?accaaaatcc?cttaacgtga 8520
gttttcgttc?cactgagcgt?cagaccccgt?agaaaagatc?aaaggatctt?cttgagatcc 8580
tttttttctg?cgcgtaatct?gctgcttgca?aacaaaaaaa?ccaccgctac?cagcggtggt 8640
ttgtttgccg?gatcaagagc?taccaactct?ttttccgaag?gtaactggct?tcagcagagc 8700
gcagatacca?aatactgtcc?ttctagtgta?gccgtagtta?ggccaccact?tcaagaactc 8760
tgtagcaccg?cctacatacc?tcgctctgct?aatcctgtta?ccagtggctg?ctgccagtgg 8820
cgataagtcg?tgtcttaccg?ggttggactc?aagacgatag?ttaccggata?aggcgcagcg 8880
gtcgggctga?acggggggtt?cgtgcacaca?gcccagcttg?gagcgaacga?cctacaccga 8940
actgagatac?ctacagcgtg?agctatgaga?aagcgccacg?cttcccgaag?ggagaaaggc 9000
ggacaggtat?ccggtaagcg?gcagggtcgg?aacaggagag?cgcacgaggg?agcttccagg 9060
gggaaacgcc?tggtatcttt?atagtcctgt?cgggtttcgc?cacctctgac?ttgagcgtcg 9120
atttttgtga?tgctcgtcag?gggggcggag?cctatggaaa?aacgccagca?acgcggcctt 9180
tttacggttc?ctggcctttt?gctggccttt?tgctcacatg?gctcgacaga?tct 9233

Claims (10)

1, a kind of recombinant plasmid that is used for two fluorescence labeling methods is characterized in that described recombinant plasmid comprises:
1) the dna fragmentation A of code tag albumin A, this label protein can be specifically and its fluorogenic substrate covalent attachment, and the dna sequence dna C that its 5 ' end or 3 ' end merge one section coding PROTEIN C to be detected forms Segment A C;
2) the dna fragmentation B of code tag protein B, this label protein can be specifically and its fluorogenic substrate covalent attachment, and the dna sequence dna D that its 5 ' end or 3 ' end merge one section coding protein D to be detected forms fragment BD;
3) described Segment A C is connected by the dna sequence dna E that one section coding internal ribosome inserts the bicistronic mRNA ORF expression system of site element with BD;
4) in one section promotor of transcribing control of being responsible for described Segment A C, E and BD of the correct position of the upstream of described Segment A C.
2, recombinant plasmid as claimed in claim 1 is characterized in that, described label protein comprises SNAP, Halo.
3, recombinant plasmid as claimed in claim 1, it is characterized in that, described fragment C and D can be in the different arbitrarily cell existence or synthetic can be translated as the dna fragmentation of polypeptide, described label protein A, B is SNAP and Halo, and described expression system sequence is IRES.
4. recombinant plasmid as claimed in claim 3 is characterized in that, described albumen to be detected is pTOM20 and LEF1, and described label protein is SNAP and Halo, and described expression system sequence is IRES.
5 recombinant plasmids as claimed in claim 4 is characterized in that, the described recombinant plasmid that is used for two fluorescin molecule marking methods is the pTOM20-SNAP-IRES-LEF1-Halo recombinant plasmid, and its sequence is shown in SEQ ID NO:1.
As each described recombinant plasmid among the claim 1-5, it is characterized in that 6, described carrier is the pIRES carrier.
7, the method for a kind of pair of fluorescin molecular cell mark is characterized in that, may further comprise the steps:
A) make up as each described recombinant plasmid that is used for two fluorescin molecule marking methods among the claim 1-6;
B) cell transfecting;
C) fluorescent mark.
8, method as claimed in claim 7 is characterized in that, described pTOM20-SNAP-IRES-LEF1-Halo construction of recombinant plasmid may further comprise the steps:
A) the LEF1 fragment is connected in the pFC14A carrier with Halo, obtains the pFC14A-LEF1 recombinant plasmid;
B) the LEF1-Halo fragment is joined in the pIRES carrier, obtain the IRES-LEF1-Halo recombinant plasmid;
C) SNAP tag fragment is joined in the IRES-LEF1-Halo recombinant plasmid, obtain the SNAP-IRES-LEF1-Halo recombinant plasmid;
D) the TOM20 fragment is joined in the SNAP-IRES-LEF1-Halo recombinant plasmid, obtain the TOM20-SNAP-IRES-LEF1-Halo recombinant plasmid.
9, method as claimed in claim 8 is characterized in that, described LEF1 fragment, SNAP tag fragment and TOM20 fragment obtain by pcr amplification.
10, method as claimed in claim 9 is characterized in that, described LEF1-Halo fragment is cut the pFC14A-LEF1 recombinant plasmid by enzyme and obtained.
CNA2008100368376A 2008-04-30 2008-04-30 Method for marking bifluorescence protein molecule cell Pending CN101570758A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2008100368376A CN101570758A (en) 2008-04-30 2008-04-30 Method for marking bifluorescence protein molecule cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2008100368376A CN101570758A (en) 2008-04-30 2008-04-30 Method for marking bifluorescence protein molecule cell

Publications (1)

Publication Number Publication Date
CN101570758A true CN101570758A (en) 2009-11-04

Family

ID=41230243

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100368376A Pending CN101570758A (en) 2008-04-30 2008-04-30 Method for marking bifluorescence protein molecule cell

Country Status (1)

Country Link
CN (1) CN101570758A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101876658A (en) * 2009-11-25 2010-11-03 华中科技大学 Method for constructing polypeptide fluorescent probe with concerted effect and nano-size effect and application thereof
CN102443595A (en) * 2011-11-11 2012-05-09 中国科学院武汉病毒研究所 Preparation method and application for dual-fluorescence reporting system with micro-RNA (ribonucleic acid) function
CN102827870A (en) * 2011-06-16 2012-12-19 天津药物研究院 Establishment of ET1 stable expression cell line and its application in drug screening
CN104568861A (en) * 2013-10-25 2015-04-29 华东理工大学 Method for detecting protein interaction based on bimolecularly complemented covalent modification mark
CN112683867A (en) * 2020-12-21 2021-04-20 复旦大学附属中山医院 Method for detecting depigmentin D on living cells in real time and application thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101876658A (en) * 2009-11-25 2010-11-03 华中科技大学 Method for constructing polypeptide fluorescent probe with concerted effect and nano-size effect and application thereof
CN101876658B (en) * 2009-11-25 2013-08-28 华中科技大学 Method for constructing polypeptide fluorescent probe with concerted effect and nano-size effect and application thereof
CN102827870A (en) * 2011-06-16 2012-12-19 天津药物研究院 Establishment of ET1 stable expression cell line and its application in drug screening
CN102443595A (en) * 2011-11-11 2012-05-09 中国科学院武汉病毒研究所 Preparation method and application for dual-fluorescence reporting system with micro-RNA (ribonucleic acid) function
CN104568861A (en) * 2013-10-25 2015-04-29 华东理工大学 Method for detecting protein interaction based on bimolecularly complemented covalent modification mark
CN112683867A (en) * 2020-12-21 2021-04-20 复旦大学附属中山医院 Method for detecting depigmentin D on living cells in real time and application thereof
CN112683867B (en) * 2020-12-21 2023-08-04 复旦大学附属中山医院 Method for detecting mesothelin D on living cells in real time and application thereof

Similar Documents

Publication Publication Date Title
CN107557393B (en) Magnetic nanomaterial-mediated CRISPR/Cas 9T cell internal delivery system and preparation method and application thereof
KR101748575B1 (en) INSulin gene knockout diabetes mellitus or diabetic complications animal model and a method for producing the same
CN101570758A (en) Method for marking bifluorescence protein molecule cell
CN102146371B (en) High glyphosate resistant variant gene and improvement method and application of high glyphosate resistant variant gene
US6455300B1 (en) Method and compositions for monitoring DNA binding molecules in living cells
US20040072352A1 (en) Expression vector for animal cell containing nuclear matrix attachment region of interferon beta
CN112852875B (en) Construction method of CD3e transgenic mouse model for tracing tumor T lymphocyte infiltration
CN107893083A (en) A kind of Human enterovirus virus D68 types infection clones and its construction method and application
US6773914B1 (en) PiggyBac transformation system
CN112251464A (en) Method for inducing gene point mutation
CN110066801B (en) Sialic acid induced expression element in bacillus subtilis and construction method
CN111870581B (en) Method for auxiliary separation of liposomes by using single-stranded DNA (deoxyribonucleic acid) nanostructure
CN107058367A (en) The construction method of the recombined bacillus subtilis of high yield Pullulanase
CA2362970A1 (en) Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
CN114317584B (en) Construction system of novel transposon mutant strain library, novel transposon mutant library and application
CN107988253A (en) Applications of one people miRNA as PRRS virus mortifier
CN111118049B (en) Plasmid vector and application thereof
KR101806129B1 (en) Method for producing of plant virus specific antibody using human scfv antibody phage display library
CN109880837B (en) Method for degrading lignin in tobacco straw
CN114107231A (en) Recombinant adeno-associated virus for realizing cell body labeling of whole brain postsynaptic neurons and application thereof
CN113481114B (en) Yeast cell surface display technology-based explosive visualization biosensor and preparation method and application thereof
KR20090020224A (en) Lentiviral vector which could induce dual gene overexpression and knockdown by tetracycline-controlled system
CN109706165A (en) The lactic acid bacteria excretion vector and its construction method, application of recombinant screen can be realized in Escherichia coli
KR101443937B1 (en) Method for production of TRACP5b
CN113774047B (en) Fish source protease gene and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091104